Cargando…
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers
Efforts to improve existing anti-HIV-1 therapies or develop preventatives have identified CCR5 as an important target and CCL5 as an ideal scaffold to sculpt potent HIV-1 entry inhibitors. We created novel human CCL5 variants that exhibit exceptional anti-HIV-1 features using recombinant lactobacill...
Autores principales: | Secchi, Massimiliano, Grampa, Valentina, Vangelista, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790001/ https://www.ncbi.nlm.nih.gov/pubmed/29382912 http://dx.doi.org/10.1038/s41598-018-20300-9 |
Ejemplares similares
-
Rational Engineering of a Sub-Picomolar HIV-1 Blocker
por: Secchi, Massimiliano, et al.
Publicado: (2022) -
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses
por: Vangelista, Luca, et al.
Publicado: (2020) -
Editorial: CCR5: A receptor at the center stage in infection
por: Ellwanger, Joel Henrique, et al.
Publicado: (2022) -
Lactobacilli: Legal Regulation and Prospects for New Generation Drugs
por: Yunes, R. A., et al.
Publicado: (2022) -
The GenePOC Platform, a Rational Solution for Extreme Point-of-Care Testing
por: Bissonnette, Luc, et al.
Publicado: (2016)